Form 4: Amgen Director Michael V. Drake Reports Acquisition of Common Stock

Director Michael V. Drake reports acquiring Amgen common stock through vested Restricted Stock Units and dividend equivalents.

Summary

• On May 7, 2024, Michael V. Drake, a director of Amgen Inc., acquired 116.5501 shares of common stock.
• The acquisition was a result of vested Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The RSUs vested immediately and are payable in shares of Amgen's common stock on a one-to-one basis.
• The reported transaction also includes 92 Dividend Equivalents (DEs) granted pursuant to the Director Program.
• Following the transaction, Drake beneficially owns 2,455.7662 shares of Amgen common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction, but director's acquisition of shares can be interpreted as a sign of confidence.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Director share acquisitions are common and are viewed as a sign of confidence in the company's prospects. This is a routine filing related to director compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals director confidence.

Key Dates